Orthofix Medical Inc
OFIX14.960USD
+0.280+1.91%
Handelsschluss 11/07, 16:00（ET）Kurse um 15 Minuten verzögert
591.20MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Orthofix Medical Inc Unternehmen
Orthofix Medical Inc. is a global medical technology company. Its Global Spine segment offers two product categories: Bone Growth Therapies and Spinal Implants, Biologics, and Enabling Technologies. Its Global Orthopedics segment offers products and solutions for limb deformity correction and complex limb reconstruction with a focus on use in trauma, adult and pediatric limb reconstruction, and foot and ankle procedures. This segment specializes in the design, development, and marketing of external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It offers a portfolio of spinal hardware, bone growth therapies, specialized orthopedic solutions, biologics and enabling technologies, including the 7D FLASH navigation system. Spinal Implants, Biologics, and Enabling Technologies includes a portfolio of spine fixation and motion preservation implant products used in surgical procedures of the spine.
Orthofix Medical Inc Informationen
BörsenkürzelOFIX
Name des UnternehmensOrthofix Medical Inc
IPO-datumApr 24, 1992
CEOMr. Massimo Calafiore
Anzahl der mitarbeiter1616
WertpapierartOrdinary Share
GeschäftsjahresendeApr 24
Addresse3451 Plano Pkwy
StadtLEWISVILLE
BörseNASDAQ Global Select Consolidated
LandUnited States of America
Postleitzahl75056-9453
Telefon12149372000
Websitehttps://ir.orthofix.com/ir-home/default.aspx
BörsenkürzelOFIX
IPO-datumApr 24, 1992
CEOMr. Massimo Calafiore
Führungskräfte von Orthofix Medical Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Jason M. Hannon
Mr. Jason M. Hannon
Independent Director
Independent Director
69.64K
+37.09%
Mr. Michael M. Finegan
Mr. Michael M. Finegan
Independent Chairman of the Board
Independent Chairman of the Board
55.80K
+87.78%
Ms. Shweta Singh Maniar
Ms. Shweta Singh Maniar
Independent Director
Independent Director
54.07K
+53.48%
Mr. Charles R. (Chuck) Kummeth
Mr. Charles R. (Chuck) Kummeth
Independent Director
Independent Director
43.29K
+77.08%
Mr. Massimo Calafiore
Mr. Massimo Calafiore
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
40.09K
+33.23%
Mr. Patrick G. Fisher
Mr. Patrick G. Fisher
President - Global Orthopedics
President - Global Orthopedics
28.05K
-6.64%
Mr. Max Reinhardt
Mr. Max Reinhardt
President - Global Spine
President - Global Spine
3.16K
-34.23%
Ms. Julie B. Andrews
Ms. Julie B. Andrews
Chief Financial Officer
Chief Financial Officer
--
--
Mr. John Bell (Jack) Henneman, III
Mr. John Bell (Jack) Henneman, III
Independent Director
Independent Director
--
--
Mr. Wayne C. Burris
Mr. Wayne C. Burris
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Jason M. Hannon
Mr. Jason M. Hannon
Independent Director
Independent Director
69.64K
+37.09%
Mr. Michael M. Finegan
Mr. Michael M. Finegan
Independent Chairman of the Board
Independent Chairman of the Board
55.80K
+87.78%
Ms. Shweta Singh Maniar
Ms. Shweta Singh Maniar
Independent Director
Independent Director
54.07K
+53.48%
Mr. Charles R. (Chuck) Kummeth
Mr. Charles R. (Chuck) Kummeth
Independent Director
Independent Director
43.29K
+77.08%
Mr. Massimo Calafiore
Mr. Massimo Calafiore
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
40.09K
+33.23%
Mr. Patrick G. Fisher
Mr. Patrick G. Fisher
President - Global Orthopedics
President - Global Orthopedics
28.05K
-6.64%
Umsatzaufteilung
Währung: USDAktualisiert: Mon, Oct 6
Währung: USDAktualisiert: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Spinal Implants
107.25M
52.80%
Bone Growth Therapies
62.57M
30.81%
Nach RegionUSD
Name
Umsatz
Anteil
United States
171.74M
84.55%
Others
16.18M
7.97%
Italy
5.65M
2.78%
France (Country)
3.18M
1.57%
United Kingdom
3.12M
1.54%
Andere
3.25M
1.60%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Spinal Implants
107.25M
52.80%
Bone Growth Therapies
62.57M
30.81%
Aktionärsstatistik
Aktualisiert: Sat, Aug 16
Aktualisiert: Sat, Aug 16
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Engine Capital Management, LP
10.74%
Rubric Capital Management LP
9.40%
Paradigm Capital Management, Inc.
8.44%
Juniper Investment Company, LLC
8.19%
Armistice Capital LLC
7.52%
Andere
55.72%
Aktionäre
Aktionäre
Anteil
Engine Capital Management, LP
10.74%
Rubric Capital Management LP
9.40%
Paradigm Capital Management, Inc.
8.44%
Juniper Investment Company, LLC
8.19%
Armistice Capital LLC
7.52%
Andere
55.72%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor/Hedge Fund
43.68%
Hedge Fund
24.84%
Investment Advisor
20.75%
Research Firm
3.06%
Individual Investor
2.43%
Bank and Trust
0.31%
Pension Fund
0.27%
Insurance Company
0.04%
Andere
4.62%
Institutionelle Beteiligung
Aktualisiert: Wed, Oct 1
Aktualisiert: Wed, Oct 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q3
360
36.43M
92.00%
-1.48M
2025Q2
383
34.24M
86.73%
-7.53M
2025Q1
400
36.08M
92.22%
-6.00M
2024Q4
406
35.79M
91.88%
-7.42M
2024Q3
405
37.21M
98.94%
-7.35M
2024Q2
405
38.09M
101.30%
-7.13M
2024Q1
403
37.91M
101.53%
-6.95M
2023Q4
403
37.82M
103.01%
-4.07M
2023Q3
385
35.80M
97.80%
-3.46M
2023Q2
374
34.87M
95.30%
-3.10M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Engine Capital Management, LP
4.25M
10.77%
--
--
Jun 30, 2025
Rubric Capital Management LP
3.72M
9.42%
+26.77K
+0.72%
Jun 30, 2025
Paradigm Capital Management, Inc.
3.34M
8.46%
+858.90K
+34.61%
Jun 30, 2025
Juniper Investment Company, LLC
2.85M
7.2%
+375.78K
+15.22%
Sep 25, 2025
Armistice Capital LLC
2.98M
7.54%
+14.00K
+0.47%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
2.87M
7.26%
+107.31K
+3.89%
Jun 30, 2025
The Vanguard Group, Inc.
2.31M
5.85%
+137.33K
+6.32%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
1.07M
2.72%
+261.68K
+32.22%
Jun 30, 2025
State Street Investment Management (US)
947.28K
2.4%
+86.94K
+10.11%
Jun 30, 2025
AYAL Capital Advisors Limited
943.20K
2.39%
+403.43K
+74.74%
Jun 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Thu, Nov 6
Aktualisiert: Thu, Nov 6
Name
Anteil
SPDR S&P Health Care Equipment ETF
0.61%
Invesco NASDAQ Future Gen 200 ETF
0.47%
Inspire Small/Mid Cap ESG ETF
0.25%
SPDR SSGA US Small Cap Low Volatility Index ETF
0.11%
iShares Micro-Cap ETF
0.11%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.1%
Texas Capital Texas Small Cap Equity Index ETF
0.08%
iShares U.S. Medical Devices ETF
0.07%
Avantis US Small Cap Equity ETF
0.06%
Texas Capital Texas Equity Index ETF
0.05%
Mehr Anzeigen
SPDR S&P Health Care Equipment ETF
Anteil0.61%
Invesco NASDAQ Future Gen 200 ETF
Anteil0.47%
Inspire Small/Mid Cap ESG ETF
Anteil0.25%
SPDR SSGA US Small Cap Low Volatility Index ETF
Anteil0.11%
iShares Micro-Cap ETF
Anteil0.11%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Anteil0.1%
Texas Capital Texas Small Cap Equity Index ETF
Anteil0.08%
iShares U.S. Medical Devices ETF
Anteil0.07%
Avantis US Small Cap Equity ETF
Anteil0.06%
Texas Capital Texas Equity Index ETF
Anteil0.05%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
